Get the Stockscreener App
16.79
0.18%
0.03
After Hours:
16.30
-0.49
-2.92%
Beta Bionics Inc stock is traded at $16.79, with a volume of 1.13M.
It is up +0.18% in the last 24 hours and up +15.32% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
See More
Previous Close:
$16.76
Open:
$17.05
24h Volume:
1.13M
Relative Volume:
2.11
Market Cap:
$727.95M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+16.35%
1M Performance:
+15.32%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$16.57
$17.50
1-Week Range:
$13.75
$17.50
52-Week Range:
$8.89
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
16.79 | 728.48M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
Beta Bionics Reports Record Growth in Earnings Call - TipRanks
Beta Bionics Insider Ups Holding By 130% During Year - simplywall.st
Beta Bionics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:BBNX) - Seeking Alpha
A Quick Look at Today's Ratings for Beta Bionics(BBNX.US), With a Forecast Between $17 to $30 - 富途牛牛
Beta Bionics, Inc.: Strong Commercial Execution and Promising Growth Prospects Drive Buy Rating - TipRanks
Analyzing recovery setups for Beta Bionics Inc. investorsReal Time Alerts Based on AI Prediction Triggered - metal.it
Published on: 2025-07-30 23:52:55 - metal.it
Beta Bionics (BBNX) Q2 Revenue Soars 54% - AOL.com
Beta Bionics stock price target raised to $21 by Truist on strong revenue - Investing.com India
Why Beta Bionics Inc. stock attracts strong analyst attentionAI Trading Suggestions With Accuracy Focus Released - beatles.ru
Beta Bionics BBNX Q2 2025 Earnings Call Transcript - AOL.com
We Think Beta Bionics (NASDAQ:BBNX) Can Afford To Drive Business Growth - Yahoo Finance
Beta Bionics Inc (BBNX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... By GuruFocus - Investing.com Canada
Beta Bionics 2025 Q2 Earnings Beats Expectations as Net Loss Narrows by 83.5% - AInvest
Beta Bionics Reports Strong Q2 Growth and Raises Guidance - TipRanks
Beta Bionics Q2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Beta Bionics Q2 2025 sees revenue growth, stock rises - Investing.com
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance - GlobeNewswire
Beta Bionics Q2 2025 presentation: Revenue soars to $23.2M, guidance raised - Investing.com
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg
Is Beta Bionics Inc. Stock Overbought or Oversold RSI Indicator AnalysisSwing Setup With Technical Confirmation Explained - metal.it
What institutions are buying Beta Bionics Inc. stock nowEarly Entry Tips With Low Risk Zone Shared - beatles.ru
How volatile is Beta Bionics Inc. stock compared to the marketTriple-digit returns - jammulinksnews.com
Should I hold or sell Beta Bionics Inc. stock in 2025Maximize your returns with portfolio optimization - jammulinksnews.com
What catalysts could drive Beta Bionics Inc. stock higher in 2025Unlock daily market insights for better trades - jammulinksnews.com
How many analysts rate Beta Bionics Inc. as a “Buy”Discover stocks with superior performance - jammulinksnews.com
What are analysts’ price targets for Beta Bionics Inc. in the next 12 monthsAccess exclusive market insights for free - jammulinksnews.com
What are Beta Bionics Inc. company’s key revenue driversMaximize returns with effective portfolio management - jammulinksnews.com
Why is Beta Bionics Inc. stock attracting strong analyst attentionBoost your returns with professional guidance - jammulinksnews.com
What are the latest earnings results for Beta Bionics Inc.Free Investment Portfolio Suggestions - jammulinksnews.com
What drives Beta Bionics Inc. stock priceUnstoppable profit momentum - Autocar Professional
Is Beta Bionics Inc. a good long term investmentStrongest growth potential - Autocar Professional
What analysts say about Beta Bionics Inc. stockRobust financial gains - Autocar Professional
Beta Bionics Inc. Stock Analysis and ForecastTriple-digit return opportunities - Autocar Professional
Beta Bionics, Inc.’s Lock-Up Period Will Expire on July 29th (NASDAQ:BBNX) - Defense World
Is Sprinklr Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
Editas Medicine Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com
NIP Group Inc. Depositary Receipt Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional
Beta Bionics Inc Stock (BBNX) Financials Data
There is no financial data for Beta Bionics Inc (BBNX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):